vonoprazan
Vonoprazan Delivers a Quick, Sustained Relief to NERD Heartburn
Patients with nonerosive reflux disease who can manage their heartburn with daily vonoprazan also report durable ...
OCTOBER 29, 2024
New Guideline for H. pylori Changes Primary Treatment Recommendation
The American College of Gastroenterology updated its 2017 guideline for treating Helicobacter pylori.
OCTOBER 2, 2024
FDA Approves Vonoprazan for NERD
The FDA has approved vonoprazan (Voquezna, Phathom) 10-mg tablets for use in patients with nonerosive reflux ...
JULY 19, 2024
Expert Picks From DDW 2024, Part 1: IBD, EoE, NERD and More
In this installment of Expert Picks from DDW 2024, Anisa Shaker, MD, discusses five of her favorite abstracts and ...
JULY 12, 2024
Upcoming H. pylori Guideline Will Have Significant Changes
Treatment guidelines being prepared for release in 2024 are expected to change first- and second-line H. pylori ...
FEBRUARY 22, 2024
P-CAB Inhibitor Versus PPI for Preventing Upper GI Rebleeding
Vonoprazan was found to provide the same protection against rebleeding of peptic ulcer hemorrhage after endoscopic ...
JULY 13, 2023
Expert Picks From ACG 2022, Part 2: Esophageal and Liver Care
Brooks D. Cash, MD, discusses his favorite research from ACG 2022, specifically innovations in esophageal and ...
JANUARY 27, 2023
Results of P-CAB Trial Bring Possibility Of a New Therapeutic for NERD
In this edition of “Just a Phase,” we look at a phase 2 trial of vonoprazan as a therapy for nonerosive ...
MAY 18, 2022
Acid Control Test: 2 New Drugs Show Benefit in Clinical Trials
San Diego—Clinical studies are keeping alive the potential for commercial development of drugs to provide ...
NOVEMBER 7, 2016
